- Home
- KPRX vs MF Comparison
KPRX vs MF Comparison
Compare KPRX & MF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | MF |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 9.5M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KPRX | MF |
|---|---|---|
| Price | $2.47 | $9.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.4K | ★ 61.3K |
| Earning Date | 11-06-2026 | 12-29-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.76 | $5.07 |
| 52 Week High | $2.91 | $22.56 |
Technical Indicators
Market Signals| Indicator | KPRX | MF |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 37.38 |
| Support Level | $2.45 | N/A |
| Resistance Level | $2.61 | $11.05 |
| Average True Range (ATR) | 0.05 | 2.05 |
| MACD | -0.01 | -0.72 |
| Stochastic Oscillator | 4.55 | 10.27 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.